RNA Therapeutics | Lessons Learned
Wednesday, May 4, 2022
The label “RNA” encompasses a wide array of biologically active agents spanning therapeutic modalities, vaccines, non-coding controls, and other forms. In this panel we will discuss a number of these forms, discuss examples of recent developments and illustrate why RNA developments represent a promising source of novel therapies and therapeutic approaches.
- Moderator:
-
- Janet Wu
-
- Anchor/Reporter, Bloomberg
- Panelists:
-
- Sarah Boyce
-
- President & CEO, Avidity Biosciences, Inc.
- Jim Burns, PhD
-
- CEO, Locanabio
- Jeannie Lee, MD, PhD
-
- Molecular Biologist, MGH
- Professor of Genetics, HMS
- Laura Sepp-Lorenzino, PhD
-
- Chief Scientific Officer, Executive Vice President, Intellia Therapeutics